Tolerability Study of a Novel Microbiome Therapeutic in Subjects With Gastroesophageal Reflux Disease
NCT04491734
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
156
Enrollment
INDUSTRY
Sponsor class
Conditions
Gastroesophageal Reflux
Interventions
DIETARY_SUPPLEMENT:
maltosyl-isomalto-oligosaccharides (MIMO)
Sponsor
ISOThrive Inc.